Skip to main content
FinSpry Logo
FinSpry
NVCR logo
NVCR
(NASDAQ)
NovoCure Limited
$10.55-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NovoCure (NVCR) Stock Price & Financial Analysis

NovoCure Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.30 - $10.87
52-Week High$20.06
52-Week Low$9.82
Open$10.52
Volume1.13M
Average Volume (3M)1.13M
Market Cap1.18B
Shares Outstanding111.47M
Price to Sales (P/S)1.84
Price to Book (P/B)3.55
EV/EBITDA-10.17
Revenue (TTM)655.35M
Net Income (TTM)-136.23M
Free Cash Flow (TTM)-75.68M
EPS (TTM)$-1.22
Profit Margin-20.79%
Operating Margin-23.47%
Return on Equity (ROE)-40.01%
Debt to Equity0.85
50-Day MA$12.12
200-Day MA$13.11
52-Week Change-38.13%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NovoCure

What is the current stock price for NVCR?

As of the latest trading session, NVCR stock trades at $10.55. The 52-week range is $9.82–$20.06, with a day range of $10.30–$10.87.

What is the P/E ratio for NVCR?

The P/E ratio (Price-to-Earnings) for NVCR is shown in the Key Statistics section. This valuation metric helps compare NovoCure Limited to industry peers.

Does NVCR pay dividends?

NovoCure does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NVCR?

Based on 2 analysts, the consensus for NVCR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NVCR?

NovoCure's market capitalization is $1.18B, classifying it as a small-cap company. NovoCure operates in the Healthcare sector within the Medical Devices industry.